马来西亚通过在2025年开展新的临床研究和产品推出,增进妇女健康。 Biotropics Malaysia advances women's health with new clinical studies and product launches for 2025.

马来西亚生物热带正在通过侧重于妇女健康,包括心血管、月经和更年期健康的临床研究,解决两性健康差异问题。 Biotropics Malaysia is addressing gender health disparities through clinical studies focusing on women's health, including cardiovascular, menstrual, and menopausal health. 他们的产品,如SLP、Nu-Femme、Physta和BioKesum,在临床试验、改善脂质特征、减少热闪光、提高认知功能等方面都取得了积极成果。 Their products like SLP+®, Nu-Femme®, Physta®, and BioKesum® have shown positive results in clinical trials, improving lipid profiles, reducing hot flashes, and enhancing cognitive function. 该公司计划在2025年发射Physta Tongkat Ali。 The company plans to launch Physta® Tongkat Ali in 2025.